A study published in this month’s issue of the European Journal of Neuroscience has found that cannabinoids may be an effective treatment for osteoarthritis.
According to the study; “Osteoarthritis is a degenerative joint disease associated with articular cartilage degradation. The major clinical outcome of osteoarthritis is a complex pain state that includes both nociceptive and neuropathic mechanisms.”
A new study published in the International Journal of Neuropsychopharmacology, and published online by the National Institute of Health, has found that cannbinoids may treat panic disorders.
“The present study investigated the effects of systemic or intra-dorsolateral periaqueductal gray (dlPAG) administration of CB1 agonists [meant to mimic cannabinoids] on behavioural changes induced in rats by predator (a live cat) exposure, a model of panic responses”, claims the study’s abstract.
A new study published in the journal Cell Immunology has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis and cannabinoids – has neuroinflammatory capabilities.
According to the study; “Here we showed that Gp1a, a highly selective CB2 [cannabinoid receptor 2] agonist, with a four log higher affinity for CB2 than CB1, reduced clinical scores and facilitated recovery in EAE [experimental autoimmune encephalomyelitis, a disease of the central nervous system] in conjunction with long term reduction in demyelination and axonal loss.”
A recent study published in the journal Molecular Metabolism and the National Institute of Health has found intriguing new evidence to suggest that cannabinoids are involved in regulating brain energy storage, as well as various neuronal functions.
According to researchers; “Type-1 cannabinoid (CB1) and leptin (ObR) receptors regulate metabolic and astroglial functions, but the potential links between the two systems in astrocytes were not investigated so far”.
The government-funded National Cancer Institute is forthright with the fact that cannabis has vast medical value, including tumor fighting capabilities.
In drastic contrast to the Drug Enforcement Administration and other government entities, the U.S. National Cancer Institute has a report published on its website which proclaims several benefits of cannabis and cannabinoids, citing numerous scientific studies to back their claims. Among the benefits of cannabis, the organization says, is its anti-tumor capabilities, its effectiveness as a painkiller, and its usefulness as an appetite stimulant.
Cannabis can help stop organs from being rejected during transplants
In the U.S. (and many other countries around the world), people are regularly denied organ transplants if they test positive for cannabis, even if they’re qualified medical cannabis patients in states where it’s legal. It turns out that, beyond being a human rights catastrophe, it may be one of the most counterproductive practices in the medical world.
Recent studies – including one published recently by the National Institute of Health – have shown that cannabinoids can actually help the body accept new organs, significantly reducing the possibility of the transplant failing (which often leads to death).
In 2013 alone, there were over 1,200 pieces of cannabis-related legislation filed throughout the United States.
2013 has (by far) surpassed the mark of most cannabis-related legislation ever introduced in the U.S., with over 1,000 proposals filed in various states. This trend isn’t slowing down anytime soon, with numerous lawmakers already planning cannabis reform legislation for the 2014 session, and with support for reform growing at a rapid pace.
A medical spray made from the cannabis plant is legal for those with multiple sclerosis in over 20 countries.
Sativex, which is made entirely of cannabis-derived cannabinoids, is legal in over 20 countries across the globe, and is pending approval in nearly a dozen more. Canada was the first nation to approve this medication for use by people suffering with multiple sclerosis.
Despite the approval of this medication, most of the countries which have approved it retain harsh criminal penalties for those possessing, growing or using cannabis in its raw form, even for medical purposes, further displaying the ever-apparent hypocrisy of cannabis prohibition.
Hemp is carbon negative.
Even when you account for its full production – from seed to product – hemp is entirely carbon negative; hemp is one of the only plants in the world that this is true of. This means that hemp production does absolutely no harm to the environment, and may actually be beneficial to it.
Given this, and given hemp’s unrivaled diversity, it’s hard to argue that hemp is a necessity for an environmentally sustainable future.
Cannabinoids derived from hemp can expand the life of dogs and cats.
Recently a product labelled under the name Canna-Pets hit store shelves across the U.S. as a legal, over-the-counter cannabis medication for pets, which can help with a variety of ailments from diabetes to muscle pain. Interestingly, after 5 years of clinical studies, it was found that this new product – which is made from cannabinoids derived from hemp – can actually expand the life of pets. It does so with absolutely no side effects.
Cannabis can alter genes.
A recent study published in the Journal of Biological Chemistry has found that THC – a compound found in cannabis – can actually alter genes, which can help treat a number of conditions, such as cancers and inflammatory diseases. The study was funded by the U.S. National Institute of Health.
Cannabis is made up of over 400 various compounds, most all of which have intense medical value.
What the government fails to acknowledge when they use the argument that “Marinol [synthetic THC] is legal, so we don’t need to legalize medical cannabis”, is that cannabis is made up of far more than just THC; cannabis actually consists of over 400 individual compounds, most all of which can be broken down and used for a variety of medical conditions. However, these compounds are most effective when taken together, which is why consuming cannabis has such intense medical value.
A study conducted by researchers at Montana State University and the University of Colorado found that states which have legalized medical cannabis have seen a significant reduction in overall traffic fatalities – an 11% reduction in total. Those behind the study claim that the reduction is due to a simultaneous reduction in alcohol consumption, which is validated by the fact that medical cannabis states have seen a large reduction in alcohol-related accidents. The study was recently updated and published in the Journal of Law and Economics.
Cannabis is an antibacterial.
Recent studies – including this one funded by the American Chemical Society and the American Society of Pharmacognosy – have shown that cannabis, as well as fabric made from industrial hemp, has antibacterial capabilities, and can actually fight off deadly bacteria such as MRSA (methicillin-resistant Staphylococcus aureus). This indicates that clothing made from hemp may actually save lives.
A new study published in the journal PLOS One as well as the National Institute of Health has found that cannabinoids can be an effective treatment for acute lung injury, or acute respiratory distress syndrome (ARDS), which is a condition caused by damage or disease to the lungs, which is often life-threatening.
The study, which was conducted by researchers at the University of São Paulo, found that: “MAGL inhibition, and consequently the increase in 2-AG levels [a naturally-occurring cannabinoid], produced anti-inflammatory effects in a murine model of LPS-induced ALI, a finding that was considered a consequence of the activation of the CB1 and CB2 receptors.”
A new study published by the National Institute of Health, which is the most comprehensive of its kind, has found that natural, herbal cannabis is a more effective medicine than pharmaceutical medicines based, or derived from cannabis and cannabinoids.
“Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant”, states the study’s abstract; “Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana).
A new study using a compound meant to mimic the medicinal effects of cannabinoids has found that activation of the body’s cannabinoid receptors – something which cannabis does naturally – can prevent, and treat hormone-sensitive prostate cancer. The study was published this month by the U.S. National Institute of Health.
According to researchers of the study; “In the in vivo treatment, compound 4 [a synthetic cannabinoid] at 2 mg/kg, blocks the growth of LNCaP tumors and reduces the growth of PC-3 tumors generated in mice.”